Company
Headquarters: Malmo, Sweden
Employees: 6,554
CEO: Mr. Joacim Lindoff
kr11.52 Billion
SEK as of July 1, 2024
US$1.09 Billion
Company | Market Cap (USD) |
---|---|
McKesson Corporation | $75.67 B |
Cencora, Inc. | $43.82 B |
Cardinal Health, Inc. | $23.31 B |
Shanghai Pharmaceuticals Holding Co. Ltd | $8.79 B |
Sinopharm Group Co. Ltd | $8.37 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, treatment and prevention of pressure injuries and leg ulcers, prevention of deep vein thrombosis, treatment of edema, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, as well as clinical consulting, maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. The company was founded in 1957 and is headquartered in Malmö, Sweden.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Arjo AB has the following listings and related stock indices.
Stock: OMX: ARJO.B wb_incandescent
Stock: FSX: A39 wb_incandescent